One of the unfortunate aspects of lung cancer is that it tends to have a high rate of recurrence. It can be treated successfully only to return, and that return often comes far too soon.

Doctors are always trying to find a competitive edge on any cancer, and finding new uses for current drugs is a common practice.

Being diagnosed with lung cancer usually means months of chemotherapy followed by a relapse. That outlook is changing for the better.

Advancements in medicine are moving toward targeted therapy - treatments that target the exact cause of an individual's cancer. These advancements are being tested in advanced lung cancer.